Efficacy and safety of polyethylene glycol dural sealant system in cranial and spinal neurosurgical procedures: Meta-analysis
- PMID: 34084610
- PMCID: PMC8168650
- DOI: 10.25259/SNI_132_2021
Efficacy and safety of polyethylene glycol dural sealant system in cranial and spinal neurosurgical procedures: Meta-analysis
Abstract
Background: We aimed to assess the efficacy of polyethylene glycol (PEG) dura sealant to achieve watertight closure, prevention of cerebrospinal fluid (CSF) leak and to investigate its possible side effects.
Methods: We searched Medline (through PubMed), Scopus, and the Cochrane Library through December 2019. We included articles demonstrating cranial or spinal procedures with the use of PEG material as a dural sealant. Data on intraoperative watertight closure, CSF leak, and surgical complications were extracted and pooled in a meta-analysis model using RevMan version 5.3 and OpenMeta (Analyst).
Results: Pooling the controlled trials showed that PEG resulted in significantly more intraoperative watertight closures than standard care (risk ratio [RR] = 1.44, 95% confidence interval [CI] [1.24, 1.66]). However, the combined effect estimate did not reveal any significant difference between both groups in terms of CSF leaks, the incidence of surgical site infections, and neurological deficits (P = 0.7, 0.45, and 0.92, respectively). On the other hand, pooling both controlled and noncontrolled trials showed significance in terms of leak and neurological complications (RR = 0.0238, 95% CI [0.0102, 0.0373] and RR = 0.035, 95% CI [0.018, 0.052]). Regarding intraoperative watertight closure, the overall effect estimate showed no significant results (RR=0.994, 95% CI [0.986, 1.002]).
Conclusion: Dura seal material is an acceptable adjuvant for dural closure when the integrity of the dura is questionable. However, marketing it as a factor for the prevention of surgical site infection is not scientifically proved. We suggest that, for neurosurgeons, using the dural sealants are highly recommended for duraplasty, skull base approaches, and in keyhole approaches.
Keywords: Dura sealant; Dural closure; Hydrogel; Polyethylene glycol.
Copyright: © 2021 Surgical Neurology International.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (Duraseal Dural Sealant System) as a dural sealant in cranial surgery.World Neurosurg. 2012 Nov;78(5):498-504. doi: 10.1016/j.wneu.2011.12.011. Epub 2011 Dec 10. World Neurosurg. 2012. PMID: 22381303 Clinical Trial.
-
Spinal sealant system provides better intraoperative watertight closure than standard of care during spinal surgery: a prospective, multicenter, randomized controlled study.Spine (Phila Pa 1976). 2015 Apr 15;40(8):505-13. doi: 10.1097/BRS.0000000000000810. Spine (Phila Pa 1976). 2015. PMID: 25646746 Clinical Trial.
-
Polyethylene glycol hydrogel spinal sealant (DuraSeal Spinal Sealant) as an adjunct to sutured dural repair in the spine: results of a prospective, multicenter, randomized controlled study.Spine (Phila Pa 1976). 2011 Nov 1;36(23):1906-12. doi: 10.1097/BRS.0b013e3181fdb4db. Spine (Phila Pa 1976). 2011. PMID: 22008746 Clinical Trial.
-
Delayed cerebrospinal fluid leak after watertight dural closure with a polyethylene glycol hydrogel dural sealant in posterior fossa surgery: case report.Neurol Med Chir (Tokyo). 2014;54(8):634-9. doi: 10.2176/nmc.cr2013-0010. Epub 2013 Dec 5. Neurol Med Chir (Tokyo). 2014. PMID: 24305019 Free PMC article. Review.
-
Effectiveness of Dural Sealants in Prevention of Cerebrospinal Fluid Leakage After Craniotomy: A Systematic Review.World Neurosurg. 2018 Oct;118:368-376.e1. doi: 10.1016/j.wneu.2018.06.196. Epub 2018 Jun 30. World Neurosurg. 2018. PMID: 29969744 Review.
Cited by
-
Hemopatch® as a primary dural sealant in cranial neurosurgery: Technical note and a retrospective study.Neurosciences (Riyadh). 2024 May;29(2):128-132. doi: 10.17712/nsj.2024.2.20230109. Neurosciences (Riyadh). 2024. PMID: 38740394 Free PMC article.
-
Clinical management of dural defects: A review.World J Clin Cases. 2023 May 6;11(13):2903-2915. doi: 10.12998/wjcc.v11.i13.2903. World J Clin Cases. 2023. PMID: 37215425 Free PMC article. Review.
References
-
- Cardona-Durán RF, Uribe JS. Spinal biologics. In: Baaj AA, Uribe J, Greenberg MS, editors. Handbook of Spine Surgery. 2nd ed. New York: Thieme; 2016. p. 948.
-
- Beierlein W, Scheule AM, Antoniadis G, Braun C, Schosser R. An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion. 2000;40:302–5. - PubMed
-
- Boogaarts JD, Grotenhuis JA, Bartels RH, Beems T. Use of a novel absorbable hydrogel for augmentation of dural repair: Results of a preliminary clinical study. Neurosurgery. 2005;57:146–51. - PubMed
-
- Cosgrove GR, Delashaw JB, Grotenhuis JA, Tew JM, van Loveren H, Spetzler RF, et al. Safety and efficacy of a novel polyethylene glycol hydrogel sealant for watertight dural repair. J Neurosurg. 2007;106:52–8. - PubMed
LinkOut - more resources
Full Text Sources